Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 39% ± 21% | |
peripheral blood | 11 studies | 24% ± 11% | |
lung | 9 studies | 24% ± 10% | |
kidney | 5 studies | 21% ± 5% | |
heart | 4 studies | 27% ± 5% | |
eye | 4 studies | 37% ± 19% | |
adipose | 4 studies | 25% ± 2% | |
bone marrow | 3 studies | 23% ± 9% | |
liver | 3 studies | 30% ± 17% | |
intestine | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3386.00 | 1445 / 1445 | 100% | 31.93 | 183 / 183 |
lung | 100% | 5179.78 | 578 / 578 | 100% | 28.52 | 1153 / 1155 |
brain | 100% | 3683.88 | 2641 / 2642 | 100% | 19.45 | 704 / 705 |
bladder | 100% | 4607.38 | 21 / 21 | 100% | 41.65 | 502 / 504 |
prostate | 100% | 4582.72 | 245 / 245 | 100% | 35.07 | 500 / 502 |
breast | 100% | 4335.25 | 459 / 459 | 100% | 28.05 | 1113 / 1118 |
intestine | 100% | 3840.47 | 966 / 966 | 99% | 22.75 | 522 / 527 |
kidney | 100% | 3557.29 | 89 / 89 | 99% | 36.31 | 892 / 901 |
thymus | 100% | 5314.12 | 653 / 653 | 99% | 27.00 | 598 / 605 |
uterus | 100% | 3983.29 | 170 / 170 | 99% | 28.54 | 453 / 459 |
ovary | 100% | 3300.51 | 180 / 180 | 99% | 16.40 | 424 / 430 |
stomach | 100% | 2635.36 | 359 / 359 | 99% | 23.82 | 282 / 286 |
pancreas | 99% | 1976.78 | 324 / 328 | 98% | 34.25 | 175 / 178 |
skin | 100% | 5450.64 | 1806 / 1809 | 97% | 32.20 | 458 / 472 |
liver | 100% | 2070.85 | 226 / 226 | 93% | 15.10 | 379 / 406 |
adrenal gland | 100% | 2742.76 | 258 / 258 | 89% | 11.71 | 204 / 230 |
adipose | 100% | 4229.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 5459.09 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.69 | 1 / 1 |
blood vessel | 100% | 3218.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2472.12 | 850 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 22.91 | 44 / 45 |
peripheral blood | 97% | 4963.22 | 900 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 13.82 | 27 / 29 |
muscle | 92% | 1448.32 | 735 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 23.00 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0099173 | Biological process | postsynapse organization |
GO_0034332 | Biological process | adherens junction organization |
GO_0042117 | Biological process | monocyte activation |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0001701 | Biological process | in utero embryonic development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0038004 | Biological process | epidermal growth factor receptor ligand maturation |
GO_0010820 | Biological process | positive regulation of T cell chemotaxis |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0051089 | Biological process | constitutive protein ectodomain proteolysis |
GO_0007162 | Biological process | negative regulation of cell adhesion |
GO_0016485 | Biological process | protein processing |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0046931 | Biological process | pore complex assembly |
GO_0007267 | Biological process | cell-cell signaling |
GO_0140249 | Biological process | protein catabolic process at postsynapse |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0090102 | Biological process | cochlea development |
GO_0098696 | Biological process | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006468 | Biological process | protein phosphorylation |
GO_1901342 | Biological process | regulation of vasculature development |
GO_0042987 | Biological process | amyloid precursor protein catabolic process |
GO_0006509 | Biological process | membrane protein ectodomain proteolysis |
GO_0099175 | Biological process | regulation of postsynapse organization |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0097060 | Cellular component | synaptic membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0097038 | Cellular component | perinuclear endoplasmic reticulum |
GO_0005925 | Cellular component | focal adhesion |
GO_0030425 | Cellular component | dendrite |
GO_0009986 | Cellular component | cell surface |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005912 | Cellular component | adherens junction |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0046930 | Cellular component | pore complex |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030424 | Cellular component | axon |
GO_0005798 | Cellular component | Golgi-associated vesicle |
GO_0097197 | Cellular component | tetraspanin-enriched microdomain |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_1902945 | Molecular function | metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0070573 | Molecular function | metallodipeptidase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005178 | Molecular function | integrin binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | ADAM10 |
Protein name | Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c) Disintegrin and metalloproteinase domain-containing protein 10 (Kuzbanian protein homolog) ADAM metallopeptidase domain 10 Alternative protein ADAM10 |
Synonyms | MADM KUZ |
Description | FUNCTION: Transmembrane metalloprotease which mediates the ectodomain shedding of a myriad of transmembrane proteins, including adhesion proteins, growth factor precursors and cytokines being essential for development and tissue homeostasis . Associates with six members of the tetraspanin superfamily TspanC8 which regulate its exit from the endoplasmic reticulum and its substrate selectivity . Cleaves the membrane-bound precursor of TNF-alpha at '76-Ala-|-Val-77' to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface . Responsible for the proteolytic release of several other cell-surface proteins, including heparin-binding epidermal growth-like factor, ephrin-A2, CD44, CDH2 and for constitutive and regulated alpha-secretase cleavage of amyloid precursor protein (APP) . Contributes to the normal cleavage of the cellular prion protein . Involved in the cleavage of the adhesion molecule L1 at the cell surface and in released membrane vesicles, suggesting a vesicle-based protease activity . Controls also the proteolytic processing of Notch and mediates lateral inhibition during neurogenesis (By similarity). Responsible for the FasL ectodomain shedding and for the generation of the remnant ADAM10-processed FasL (FasL APL) transmembrane form . Also cleaves the ectodomain of the integral membrane proteins CORIN and ITM2B . Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R and IL11RA, leading to the release of secreted forms of IL6R and IL11RA . Enhances the cleavage of CHL1 by BACE1 (By similarity). Cleaves NRCAM (By similarity). Cleaves TREM2, resulting in shedding of the TREM2 ectodomain . Involved in the development and maturation of glomerular and coronary vasculature (By similarity). During development of the cochlear organ of Corti, promotes pillar cell separation by forming a ternary complex with CADH1 and EPHA4 and cleaving CADH1 at adherens junctions (By similarity). May regulate the EFNA5-EPHA3 signaling . Regulates leukocyte transmigration as a sheddase for the adherens junction protein VE-cadherin/CDH5 in endothelial cells . .; FUNCTION: (Microbial infection) Promotes the cytotoxic activity of S.aureus hly by binding to the toxin at zonula adherens and promoting formation of toxin pores. . |
Accessions | H3BS53 ENST00000396136.6 ENST00000561288.1 C9J9B4 ENST00000559053.1 ENST00000402627.5 B5MC71 ENST00000439637.5 H0YK87 ENST00000558004.1 ENST00000461408.2 H0YK32 L8E9R5 H0YNC5 O14672 A0AV88 ENST00000260408.8 [O14672-1] A0A087WYG1 |